- Home
- IOTR vs INKT Comparison
IOTR vs INKT Comparison
Compare IOTR & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- INKT
- Stock Information
- Founded
- IOTR 2019
- INKT 2017
- Country
- IOTR Singapore
- INKT United States
- Employees
- IOTR N/A
- INKT N/A
- Industry
- IOTR
- INKT Medicinal Chemicals and Botanical Products
- Sector
- IOTR
- INKT Health Care
- Exchange
- IOTR NYSE
- INKT Nasdaq
- Market Cap
- IOTR 29.5M
- INKT 31.2M
- IPO Year
- IOTR 2025
- INKT 2021
- Fundamental
- Price
- IOTR $0.47
- INKT $7.03
- Analyst Decision
- IOTR
- INKT Strong Buy
- Analyst Count
- IOTR 0
- INKT 2
- Target Price
- IOTR N/A
- INKT $37.50
- AVG Volume (30 Days)
- IOTR 651.9K
- INKT 5.4K
- Earning Date
- IOTR 01-01-0001
- INKT 05-15-2025
- Dividend Yield
- IOTR N/A
- INKT N/A
- EPS Growth
- IOTR N/A
- INKT N/A
- EPS
- IOTR N/A
- INKT N/A
- Revenue
- IOTR $9,578,336.00
- INKT N/A
- Revenue This Year
- IOTR N/A
- INKT N/A
- Revenue Next Year
- IOTR N/A
- INKT N/A
- P/E Ratio
- IOTR N/A
- INKT N/A
- Revenue Growth
- IOTR 13.93
- INKT N/A
- 52 Week Low
- IOTR $0.31
- INKT $4.56
- 52 Week High
- IOTR $5.98
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- INKT 44.59
- Support Level
- IOTR N/A
- INKT $6.89
- Resistance Level
- IOTR N/A
- INKT $7.40
- Average True Range (ATR)
- IOTR 0.00
- INKT 0.53
- MACD
- IOTR 0.00
- INKT -0.01
- Stochastic Oscillator
- IOTR 0.00
- INKT 40.59
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.